AmplifyBio and Xcell Biosciences Announce Partnership to Manufacture Solid Tumor-Targeting TCR-T Cell Therapy
Companies will jointly work through process development, preclinical analysis, and first-in-human trials using Xcellbio’s AVATAR FoundryTM platform SAN FRANCISCO and SOUTH SAN FRANCISCO, CA — May 20, 2024 – Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly growing contract development and manufacturing organization, […]
AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture
AmplifyBio and RNAV8 Bio Announce Strategic Partnership to Support mRNA Therapeutic Developers from Sequence Design to GMP Manufacture AmplifyBio, a Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) focused on differentiating services that cover target optimization, preclinical safety studies, and manufacturing scale-up, and RNAV8 Bio, an emerging startup focused on mRNA engineering […]
The End of Buy vs. Build Analyses in Manufacturing: Making Way for Hybrid Approaches and Better COGS
An abridged transcript of the fireside chat from January 17th, 2024, at Advanced Therapies week in Miami, Florida with J. Kelly Ganjei, CEO AmplifyBio. Moderator: What led you to the strategy for building Amplify Bío that includes advanced characterization services, safety and tox preclinical services, and manufacturing in an unconventional model that allows for the […]
AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio
AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio [New Albany, Ohio, February 1, 2024] — AmplifyBio, a leading commercialization partner for advanced therapies that include cell and gene therapies, proudly announces the successful grand opening of the AmplifyBio Manufacturing Enablement Center (AMEC) in New Albany, Ohio. The milestone event follows the […]
AmplifyBio Goes Live with ValGenesis VLMS
SANTA CLARA, Calif., Dec. 12, 2023 /PRNewswire/ — ValGenesis, Inc., the market leader in enterprise validation lifecycle management solutions, announced that AmplifyBio, a rapidly growing contract research organization (CRO), successfully went live with the ValGenesis validation lifecycle management system (VLMS) to efficiently manage digital validation processes. AmplifyBio spun out from Battelle, the world’s largest independent nonprofit applied […]
AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity
WEST JEFFERSON, Ohio, November 7, 2023 (Newswire.com) – AmplifyBio, a leading service provider in discovery, safety, and manufacturing services for the development of advanced therapies, has chosen Apprentice.io’s cutting-edge Tempo Manufacturing Execution System (MES) to expand production capabilities and meet the increasing demand for modern modality commercialization on shorter de-risked timelines. Apprentice’s, no-code, fully cloud-native […]
AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics
WEST JEFFERSON, Ohio, & GAITHERSBURG, Md., October 31, 2023 (Newswire.com) – AmplifyBio, a leading service provider for the commercialization of advanced modality therapeutics, and Vector BioMed, a biomanufacturing company specializing in the manufacture of lentiviral vectors, announced a strategic partnership that aims to accelerate the development of lentiviral vector-based gene therapeutics. This collaboration brings together […]
AmplifyBio ISAM 2023 Poster
AmplifyBio Inhalation ISAM 2023 Poster Download the Poster Presented by AmplifyBio at the International Society of Aerosols in Medicine Meeting In this poster, AmplifyBio examines an approach to estimate the mass of aerosolized fluorescent particles deposited in the lung of the rat by inhalation using a whole-body spectrometer using IRDye 800CW Carboxylate, biologically inert, as […]
AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients
WEST JEFFERSON, Ohio, July 12, 2023 (Newswire.com) – AmplifyBio, a leading service provider for the commercialization of advanced modality therapeutics, such as cell and gene therapies, today announced the successful acquisition of a cutting-edge intellectual property (IP) that, among other capabilities, will allow them to offer non-viral gene-editing services to clients. The move represents a significant […]
AmplifyBio Celebrates 2 Years of Innovative Solutions in Preclinical Drug Development and Safety
WEST JEFFERSON, Ohio, May 25, 2023 (Newswire.com) – AmplifyBio, an organization built from a preclinical CRO, launched out of Battelle in 2021 and dedicated to building a full-service advanced therapy commercialization hub, is proud to celebrate its two-year anniversary. Since its inception, AmplifyBio has been committed to improving the speed and cost-effectiveness of bringing safe, efficacious […]
